Hassard James

Hassard James is listed in filings as Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX). This profile follows SEC Form 4 activity through Jul 9, 2024, including sale activity. Recent filings connect the profile to Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX). The current snapshot covers public activity from Jun 24, 2024 to Jul 9, 2024. Reported amounts are shown as $669.9K to $661.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.